Hepatology
Feature
Can a nationwide liver paired donation program work?
The program will require a donor (and a support person) to travel to the recipient’s transplant center where the surgery will be performed. A...
From the Journals
FAST score appears accurate for diagnosis of fibrotic NASH
The score may also reduce the number of patients undergoing unnecessary liver biopsy.
From the Journals
Components of coffee other than caffeine linked to reduced NAFLD severity
Consumption of regular or decaf coffee was negatively associated with fatty liver measures in overweight adults, including those with type 2...
From the Journals
Strong support to provide DAA therapy to all patients with HCV
The findings highlight a “substantial need to provide DAA therapy to all patients with HCV, regardless of disease stage or financial status.”
From the Journals
Nonheavy alcohol use associated with liver fibrosis, NASH
“Our results call this strict categorization into question, suggesting that even nonheavy alcohol use should be considered as a factor...
From the Journals
Liver cancer exacts high financial toll on older adults
In the first year after a hepatocellular carcinoma diagnosis median Medicare payments exceed $65,000.
Feature
Direct-acting antivirals tied to better outcomes in chronic Hep C
Researchers saw a significant reduction in all-cause mortality over a decade with direct-acting antivirals compared with no treatment.
Conference Coverage
A bold national plan to eliminate HCV by 2050
“We don’t get to use the ‘eliminate’ word all that often with a disease that’s taking thousands or tens of thousands – or worldwide, hundreds of...
Commentary
How a cheap liver drug may be the key to preventing COVID
The authors of a paper appearing in Nature give us multiple, complementary lines of evidence.
Conference Coverage
Poor NAFLD outcomes with increased VCTE-measured liver stiffness
The findings show that “progression to LSM-defined cirrhosis by VCTE is strongly associated with poor clinical outcomes.”
Conference Coverage
Midodrine may be comparable to albumin for PICD prevention in ACLF
Given the small size of the open-label study, with only 25 patients in each arm, the results should be considered as proof of concept and need to...